Macular degeneration is an eye condition which damages the central part of the retina where straight, clear vision takes place, threatening blindness if not treated early enough. Regular comprehensive eye exams can detect macular degeneration.

Doctor Singerman has written and edited three textbooks, as well as serving on editorial boards of major ophthalmology journals. Additionally, he regularly participates in clinical trials of new treatments for macular degeneration and retinal vascular diseases.

David Dao

Age-related macular degeneration is a condition that damages central vision. It occurs when tiny blood vessels form beneath your retina and leak fluid and blood, damaging photoreceptors in your macula and leading to blurry central vision. Routine eye exams can detect macular degeneration before it progresses further and leads to severe vision loss; its early stages usually show no symptoms; you can test for macular degeneration with a dilated exam.

Eye doctors specializing in macular degeneration will use eye drops that dilate your eyes, making them sensitive to light and blurry for several hours – this allows them to look for signs of macular degeneration within your retina and detect changes due to macular degeneration using OCT machines.

Dr. David Dao is a dual fellowship trained vitreoretinal surgeon committed to improving his patients’ lives. He has published over 120 peer-reviewed papers, meeting abstracts and textbook chapters; served as principal or co-investigator in over 40 national clinical trials that assessed new medications, surgical innovations or devices for treating vitreoretinal disorders including diabetic retinopathy, macular degeneration retinal vein occlusions or intraocular infections such as endophthalmitis; reviewed for various medical journals.

David Slade

Doctor Slade is a partner at Slade & Baker Vision Center. He has performed over 20,000 laser eye surgeries and written many books, textbooks and scientific medical articles about them. In fact, he was the first surgeon in America to perform LASIK and is considered a pioneer of refractive surgery. Additionally, he co-founded and served as president of American Society for Cataract and Refractive Surgery from 2004-2005; developed the INTRALASE bladeless version of LASIK; trained 8,000 refractive surgeons globally; created Crystalens; an anti presbyopia treatment lens with high performance capabilities.

Age-related macular degeneration (AMD) is a serious eye condition that causes blurry central vision and, over time, blindness. The primary cause is when light-sensing cells within the macula of the retina break down and cease functioning properly; although both eyes may be affected by AMD early diagnosis and treatment should prevent total blindness from occuring.

Doctor Masket earned his MD from New York Medical College and completed residency at the Bascom Palmer Eye Institute in Miami. Since then, he has published over 100 peer-reviewed articles. In addition, he is the official eye doctor for Boston Bruins, Red Sox and Patriots sports teams; performed thousands of cataract, glaucoma and laser procedures; devised multiple surgical techniques to treat complex retinal detachments including perfluoropropane gas treatment of wet macular degeneration to eliminate leakage or bleeding associated with wet macular degeneration; developed several surgical techniques to treat complex retinal detachments including revolutionary perfluoropropane gas treatment of wet macular degeneration which removes leakage associated with wet macular degeneration; performed thousands of cataract, glaucoma and laser operations as well.

David Durrie

The macula is an integral component of retina that handles central vision. It converts light to nerve signals that travel down the optic nerve and into the brain, creating blurry or fuzzy images, difficulty reading, focusing on close objects or blindness if left untreated. Macular degeneration’s milder forms – dry macular degeneration can gradually cause loss of central vision whereas wet macular degeneration causes rapid and severe vision loss that causes difficulties with recognising faces, finding objects or driving; both cases primarily affect people over 55 and is the leading cause of legal blindness within the United States.

Eye care professionals can treat wet macular degeneration with anti-angiogenic drugs injected directly into a patient. These medications stop new blood vessels from growing into the eye, as well as block leakage from abnormal ones that contribute to wet macular degeneration, helping patients regain some of their central vision.

Dr. Durrie earned his MD at Dartmouth Medical School and completed his ophthalmology residency at Manhattan Eye Ear & Throat Hospital. Throughout his career, Dr. Durrie has lectured on recent advances in cataract & corneal surgery; additionally he invented several popular surgical tools such as the Dell Astigmatism Marker and Dell Fixation Ring.

Paul H. Ernest

Dr. Ernest has years of experience treating various eye conditions, such as age related macular degeneration. He strongly emphasizes forming a partnership with his patients and spends the time to explain their condition, discuss management options and answer any questions they may have. Furthermore, he offers preventive health care through comprehensive eye exams with retinal imaging capabilities.

He is currently professor and chairman of ophthalmology at New York-Presbyterian Hospital/Weill Cornell Medical Center as well as John Milton McLean Professor of Ophthalmology at Columbia University College of Physicians and Surgeons. His research interests focus on improving macular disease diagnoses through ultrasound techniques as well as finding innovative treatment approaches.

Dr. Paul earned his MD at Loyola-Stritch School of Medicine and completed residency at Massachusetts Eye and Ear Infirmary of Harvard Medical School, specializing in retinal diseases and surgery and performing thousands of cataract and cornea operations. Additionally, he participated in clinical trials investigating better ways to treat macular degeneration as well as other eye diseases; joining many clinical trials himself aiming at this aim. Additionally he was elected into membership with American Academy of Ophthalmology while authoring or co-authoring nine books and over 270 peer-reviewed publications over his career span of practice.

Scott W. Cousins

The macula is an integral component of retina, turning light into nerve signals sent directly to your brain for processing. These nerve signals allow you to see fine detail, drive a car, read books or newspapers, as well as experience macular degeneration affecting its central part, leading to blurred or absent central vision as well as difficulty seeing straight lines and objects, but rarely leading to total blindness. Dr. Cousins offers treatment for both types of macular degeneration – dry macular degeneration is typically less serious while wet macular degeneration – that focuses on treating both types for best possible outcomes.

Berkeley Heights Eye Group provides comprehensive ophthalmology services throughout New Jersey. Their experienced doctors offer personalized attention and foster long-term relationships with each patient they treat, conducting comprehensive consultations to help each person understand their condition so that together they can make decisions regarding treatment.

Macular degeneration often presents no visible symptoms during its early stages; however, a routine dilated eye exam can detect it. Eye drops will be used to dilate your eyes so your doctor can examine their interior with greater ease; during this test they look out for distortion in straight lines and gradual loss of central vision as potential telltale signs.

Peter Masket

Macular degeneration (AMD) is an eye disease affecting the retina of both eyes. It damages central vision needed for reading, driving and recognising faces; however, peripheral vision remains intact so total blindness doesn’t occur; most frequently seen is dry macular degeneration which occurs when light-sensing cells within the macula deteriorate over time.

The rarer “wet” form of macular degeneration occurs when abnormal blood vessels form beneath the retina and leak fluid and blood, damaging the macula. This form may result in rapid loss of central vision as well as lifestyle adjustments needed to preserve central vision, so dilated eye exams are the ideal way to detect macular degeneration in this form.

Dr. Masket has published several textbooks on retinal diseases and serves on several editorial boards for major ophthalmology journals. Additionally, he chairs and directs CME courses focused on macular degeneration and retinal vascular disease.

Photodynamic therapy, using VEteporfin to attack new blood vessels, blocks leakage, and preserves vision loss is an effective solution to wet AMD. Simply place medication into both eyes before using laser light to activate them for best results.

John Coleman

Human eyes are complex structures made up of multiple parts that work together to give us clear vision. This includes your retina and macula, which process colors you see and fine details in central vision. Macular degeneration, an age-related disease in which macular pigment cells degenerate over time resulting in blurry or distorted central vision; macular degeneration often manifests itself with age as people lose central vision completely if left untreated; regular eye exams, healthy diet and at-home testing with an Amsler grid can keep your eyes healthy while alerting you to changes that might arise within your vision!

Dr. Coleman is actively involved in clinical trials to discover new and better treatments for macular degeneration and retinal diseases, and encourages his patients to make use of innovative anti-VEGF injections as they may improve visual results for those suffering from wet macular degeneration.

Dr. Bressler graduated with honors from Smith College before attending Johns Hopkins University School of Medicine to study ophthalmology. After her residency and fellowship were complete at Wilmer Eye Institute, she went on to serve on multiple editorial boards of major ophthalmology journals as an American Academy of Ophthalmology member.